Authors: Roy Martin, DVM, NAMSA; Cheryl Carlson and Daniel Singer, Data Sciences International
Preclinical studies in test models can help both researchers and regulators assess the potential effects in humans of new devices and therapies. Continuous 24-hour monitoring using implantable sensors provides data about the effects of a therapy or device on wide array of physiologic and body system parameters. Implantable sensors in free-roaming test subjects are particularly useful not only because the data they collect are not confounded by anesthesia, stress, or interaction with handlers, but also because they minimize the number of test models needed to evaluate a therapy. Today’s sensor and data management technologies offer the potential to speed medical innovation and provide patients with greatly needed medical innovations.